Baird Downgrades Envista Holdings to Neutral, Lowers Price Target to $26
10/15/2026
Impact: -75
Healthcare
Baird analyst Jeff Johnson has downgraded Envista Holdings (NYSE: NVST) from an Outperform rating to Neutral. Additionally, the price target for the stock has been reduced from $34 to $26.
AI summary, not financial advice
Share: